Terror worries may slow progress in medical devicesPhysicians say ‘chill’ is affecting manufacturers New U.S. cardiac guidelines cause a ruckusCanadian experts deliver their takes on LDL targets and risk assessment Adempas for chronic thromboembolic pulmonary hypertension First drug approved to treat rare type of pulmonary hypertension. MIs differ in younger women Simple survey in the pharmacy could help heart failure patients Pilot program shows pharmacists could do more in disease management and detection Drug tackles asthma, COPD Stent guidelines need rethink Airports bad for the heart Preventive angioplasty fends off new cardiac events But controversial strategy increases procedure time New biomarker aids MI diagnosis Combining copeptin and troponin helps rule out heart attack First Previous 51 52 53 54 55 Next Last
